
Volibose 0.2mg Tablet
Marketer
Scott Edil Pharmacia Ltd
Salt Composition
Voglibose (0.2mg)
Overview Volibose 0.2mg Tablet
Acarbose 0.2mg tablets manage type 2 diabetes by regulating post-prandial blood glucose. Prescribed when dietary changes and other medications prove insufficient to control elevated blood sugar, this medication is taken immediately before meals. Dosage and frequency are determined by your physician to optimize blood sugar control. Discontinuing this medication abruptly is unsafe and may lead to dangerously high blood sugar levels, potentially causing serious complications including renal impairment and vision loss. This treatment requires a comprehensive approach including diet, exercise, and weight management as advised by your doctor, along with regular blood glucose monitoring. Common side effects include abdominal discomfort, bloating, decreased appetite, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While acarbose alone does not induce hypoglycemia, combining it with other diabetes medications (particularly insulin or sulfonylureas) increases this risk. If hypoglycemia occurs, treat it with plain glucose; sucrose is ineffective. Inform your doctor of any kidney or liver conditions, or if you have bowel inflammation (e.g., Crohn's disease or ulcerative colitis) before starting treatment. Consult your doctor before use if pregnant or breastfeeding. Always disclose all medications to your doctor to ensure safe use. Limit alcohol consumption while taking this medication to minimize the risk of hypoglycemia.
Primary Ingredients of Volibose 0.2mg Tablet
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Volibose 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Volibose 0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer the 0.2mg Volibose tablet on an empty stomach.
Common Side effects of Volibose 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Volibose 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer the 0.2mg Volibose tablet on an empty stomach.
How Volibose 0.2mg Tablet works:
Volibose 0.2mg tablets are used to manage diabetes. They work by blocking enzymes in the intestines that digest complex carbohydrates, thus moderating post-meal blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Volibose 0.2mg Tablet with alcohol is strongly discouraged due to safety concerns.
PregnancySAFE IF PRESCRIBED
Use of the medication Volibose 0.2mg Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of 0.2mg Volibose tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Volibose 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Volibose 0.2mg tablets. A modified dosage of Volibose 0.2mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.2mg Volibose tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Volibose 0.2mg Tablet :
Omit any missed Volibose 0.2mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Volibose 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Actions | Alpha-glucosidase inhibitors |
